Summary of Study ST004164
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002624. The data can be accessed directly via it's Project DOI: 10.21228/M8G84H This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST004164 |
| Study Title | Equilibrative Nucleoside Transporter 2 Modulates Inosine Catabolism to Influence Astrocyte Metabolism and Reactivity |
| Study Summary | In this study, we demonstrate that inosine functions as an essential energy substrate for astrocytes under inflammatory conditions. Targeted metabolomic datasets were generated from mouse primary astrocytes after 24 hours of cytokine cocktail treatment. Metabolomic profiling, combined with pharmacological approaches, revealed that Ent2 regulates inosine efflux and is critical for maintaining astrocytic energy balance. Pharmacological inhibition of inosine utilization in energy-producing pathways with Forodesine led to disrupted energy homeostasis and increased astrocytic reactivity. The datasets include both raw and processed metabolomic files. Metabolomic analyses were performed at the Metabolomics Core Facility, Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan. |
| Institute | Institute of Biomedical Sciences, Academia Sinica |
| Last Name | Chern |
| First Name | Yijuang |
| Address | 128 Section 2, Academia Road, Nankang, Taipei, 115201, Taiwan |
| bmychern@ibms.sinica.edu.tw | |
| Phone | +886-2-26523913 |
| Submit Date | 2025-08-28 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzML |
| Analysis Type Detail | LC-MS |
| Release Date | 2025-09-30 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002624 |
| Project DOI: | doi: 10.21228/M8G84H |
| Project Title: | Equilibrative Nucleoside Transporter 2 Modulates Inosine Catabolism to Influence Astrocyte Metabolism and Reactivity |
| Project Summary: | Astrocytes are central regulators of brain function and exhibit diverse reactive states in response to injury and inflammation. Although the mechanisms underlying these states remain debated, cellular energy metabolism is thought to play a crucial role. This project aimed to define the role of equilibrative nucleoside transporter 2 (Ent2) in regulating astrocytic responses to inflammatory stimulation, with a particular focus on its function in inosine metabolism and energy balance. Using mouse primary astrocytes exposed to cytokine-induced activation, together with targeted metabolomic profiling and pharmacological manipulation, we examined how Ent2 activity influences purine metabolism and reactivity. Our findings show that inosine is an essential energy substrate during inflammation and that Ent2 is required to regulate inosine efflux and maintain ATP production. Loss of Ent2, or pharmacological inhibition of inosine catabolism, disrupted energy homeostasis, impaired mitochondrial function, and enhanced astrocytic reactivity. These results establish an Ent2-inosine-PNP axis as a critical pathway linking purine metabolism to astrocytic reactivity. |
| Institute: | Institute of Biomedical Sciences, Academia Sinica |
| Last Name: | Chern |
| First Name: | Yijuang |
| Address: | 128 Section 2, Academia Road, Nankang, Taipei, 115201, Taiwan |
| Email: | bmychern@ibms.sinica.edu.tw |
| Phone: | +886-2-2652-3913 |
Subject:
| Subject ID: | SU004315 |
| Subject Type: | Cultured cells |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
Factors:
Subject type: Cultured cells; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Sample source | Genotype | treatment |
|---|---|---|---|---|
| SA481171 | KO_3_Cytokine | mouse primary astrocytes | Ent10 knockout | TNF𝝰/IL-1𝝰 |
| SA481172 | p_KO_3_Cytokine | mouse primary astrocytes | Ent10 knockout | TNF𝝰/IL-1𝝰 |
| SA481173 | KO_4_Cytokine | mouse primary astrocytes | Ent11 knockout | TNF𝝰/IL-1𝝰 |
| SA481174 | p_KO_4_Cytokine | mouse primary astrocytes | Ent11 knockout | TNF𝝰/IL-1𝝰 |
| SA481175 | p_KO_5_Cytokine | mouse primary astrocytes | Ent12 knockout | TNF𝝰/IL-1𝝰 |
| SA481176 | KO_5_Cytokine | mouse primary astrocytes | Ent12 knockout | TNF𝝰/IL-1𝝰 |
| SA481177 | p_KO_6_Cytokine | mouse primary astrocytes | Ent13 knockout | TNF𝝰/IL-1𝝰 |
| SA481178 | KO_6_Cytokine | mouse primary astrocytes | Ent13 knockout | TNF𝝰/IL-1𝝰 |
| SA481179 | p_KO_7_Cytokine | mouse primary astrocytes | Ent14 knockout | TNF𝝰/IL-1𝝰 |
| SA481180 | KO_7_Cytokine | mouse primary astrocytes | Ent14 knockout | TNF𝝰/IL-1𝝰 |
| SA481181 | p_KO_1_CytokinePlusForo | mouse primary astrocytes | Ent15 knockout | TNF𝝰/IL-1𝝰/Forodesine |
| SA481182 | KO_1_CytokinePlusForo | mouse primary astrocytes | Ent15 knockout | TNF𝝰/IL-1𝝰/Forodesine |
| SA481183 | KO_2_CytokinePlusForo | mouse primary astrocytes | Ent16 knockout | TNF𝝰/IL-2𝝰/Forodesine |
| SA481184 | p_KO_2_CytokinePlusForo | mouse primary astrocytes | Ent16 knockout | TNF𝝰/IL-2𝝰/Forodesine |
| SA481185 | p_KO_3_CytokinePlusForo | mouse primary astrocytes | Ent17 knockout | TNF𝝰/IL-3𝝰/Forodesine |
| SA481186 | KO_3_CytokinePlusForo | mouse primary astrocytes | Ent17 knockout | TNF𝝰/IL-3𝝰/Forodesine |
| SA481187 | KO_4_CytokinePlusForo | mouse primary astrocytes | Ent18 knockout | TNF𝝰/IL-4𝝰/Forodesine |
| SA481188 | p_KO_4_CytokinePlusForo | mouse primary astrocytes | Ent18 knockout | TNF𝝰/IL-4𝝰/Forodesine |
| SA481189 | p_KO_5_CytokinePlusForo | mouse primary astrocytes | Ent19 knockout | TNF𝝰/IL-5𝝰/Forodesine |
| SA481190 | KO_5_CytokinePlusForo | mouse primary astrocytes | Ent19 knockout | TNF𝝰/IL-5𝝰/Forodesine |
| SA481193 | KO_6_CytokinePlusForo | mouse primary astrocytes | Ent20 knockout | TNF𝝰/IL-6𝝰/Forodesine |
| SA481194 | p_KO_6_CytokinePlusForo | mouse primary astrocytes | Ent20 knockout | TNF𝝰/IL-6𝝰/Forodesine |
| SA481195 | p_KO_7_CytokinePlusForo | mouse primary astrocytes | Ent21 knockout | TNF𝝰/IL-7𝝰/Forodesine |
| SA481196 | KO_7_CytokinePlusForo | mouse primary astrocytes | Ent21 knockout | TNF𝝰/IL-7𝝰/Forodesine |
| SA481191 | KO_1_Ctrl | mouse primary astrocytes | Ent2 knockout | Vehicle |
| SA481192 | p_KO_1_Ctrl | mouse primary astrocytes | Ent2 knockout | Vehicle |
| SA481197 | p_KO_2_Ctrl | mouse primary astrocytes | Ent3 knockout | Vehicle |
| SA481198 | KO_2_Ctrl | mouse primary astrocytes | Ent3 knockout | Vehicle |
| SA481199 | p_KO_3_Ctrl | mouse primary astrocytes | Ent4 knockout | Vehicle |
| SA481200 | KO_3_Ctrl | mouse primary astrocytes | Ent4 knockout | Vehicle |
| SA481201 | KO_4_Ctrl | mouse primary astrocytes | Ent5 knockout | Vehicle |
| SA481202 | p_KO_4_Ctrl | mouse primary astrocytes | Ent5 knockout | Vehicle |
| SA481203 | KO_5_Ctrl | mouse primary astrocytes | Ent6 knockout | Vehicle |
| SA481204 | p_KO_5_Ctrl | mouse primary astrocytes | Ent6 knockout | Vehicle |
| SA481205 | KO_6_Ctrl | mouse primary astrocytes | Ent7 knockout | Vehicle |
| SA481206 | p_KO_6_Ctrl | mouse primary astrocytes | Ent7 knockout | Vehicle |
| SA481207 | KO_1_Cytokine | mouse primary astrocytes | Ent8 knockout | TNF𝝰/IL-1𝝰 |
| SA481208 | p_KO_1_Cytokine | mouse primary astrocytes | Ent8 knockout | TNF𝝰/IL-1𝝰 |
| SA481209 | p_KO_2_Cytokine | mouse primary astrocytes | Ent9 knockout | TNF𝝰/IL-1𝝰 |
| SA481210 | KO_2_Cytokine | mouse primary astrocytes | Ent9 knockout | TNF𝝰/IL-1𝝰 |
| SA481211 | p_WT_3_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481212 | p_WT_7_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481213 | p_WT_6_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481214 | p_WT_5_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481215 | p_WT_4_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481216 | WT_2_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481217 | p_WT_2_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481218 | p_WT_1_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481219 | WT_1_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481220 | WT_3_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481221 | WT_4_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481222 | WT_7_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481223 | WT_6_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481224 | WT_5_Cytokine | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰 |
| SA481225 | WT_1_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰/Forodesine |
| SA481226 | p_WT_1_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-1𝝰/Forodesine |
| SA481227 | WT_2_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-2𝝰/Forodesine |
| SA481228 | p_WT_2_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-2𝝰/Forodesine |
| SA481229 | WT_3_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-3𝝰/Forodesine |
| SA481230 | p_WT_3_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-3𝝰/Forodesine |
| SA481231 | WT_4_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-4𝝰/Forodesine |
| SA481232 | p_WT_4_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-4𝝰/Forodesine |
| SA481233 | p_WT_5_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-5𝝰/Forodesine |
| SA481234 | WT_5_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-5𝝰/Forodesine |
| SA481235 | p_WT_6_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-6𝝰/Forodesine |
| SA481236 | WT_6_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-6𝝰/Forodesine |
| SA481237 | p_WT_7_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-7𝝰/Forodesine |
| SA481238 | WT_7_CytokinePlusForo | mouse primary astrocytes | Wild-type | TNF𝝰/IL-7𝝰/Forodesine |
| SA481239 | WT_1_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481240 | p_WT_6_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481241 | p_WT_5_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481242 | p_WT_4_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481243 | p_WT_3_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481244 | p_WT_2_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481245 | WT_2_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481246 | WT_6_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481247 | WT_5_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481248 | WT_4_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481249 | WT_3_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| SA481250 | p_WT_1_Ctrl | mouse primary astrocytes | Wild-type | Vehicle |
| Showing results 1 to 80 of 80 |
Collection:
| Collection ID: | CO004308 |
| Collection Summary: | Primary astrocytes were isolated from the brains of wild-type or ENT2-/- mice at postnatal day 1 (P1). On DIV27, cells were stimulated with a cytokine cocktail, and metabolites were extracted on DIV28 using 0.6N perchloric acid (PCA). |
| Collection Protocol Filename: | culture_and_collection_protocol.pdf |
| Sample Type: | Astrocyte cells |
Treatment:
| Treatment ID: | TR004324 |
| Treatment Summary: | Ent2+/+ and Ent2-/- primary astrocytes were treated on DIV27 with TNFα (30 ng/mL) and IL-1α (3 ng/mL) for 24 hours to induce activation. To inhibit PNP activity, Forodesine (2 μM) was applied simultaneously with cytokine treatment. |
| Treatment Protocol Filename: | Treatment_protocol_24h.pdf |
Sample Preparation:
| Sampleprep ID: | SP004321 |
| Sampleprep Summary: | Primary astrocytes were washed, digested, and subjected to metabolite extraction using 0.6 N perchloric acid (PCA), followed by neutralization with K₂CO₃. The clarified supernatants were collected and used for metabolomic profiling. The remaining protein pellets were processed separately and retained for concentration measurement. |
| Sampleprep Protocol Filename: | PCA_extraction.pdf |
| Extract Storage: | -80℃ |
Chromatography:
| Chromatography ID: | CH005250 |
| Instrument Name: | Agilent 1290 Infinity II UPLC system |
| Column Name: | ACQUITY UPLC BEH Amide (100 x 2.1 mm, 1.7 μm) |
| Column Temperature: | 40℃ |
| Flow Gradient: | 0–8 min, 90-50% B; 8–10 min, 50% B; 10–11 min, 50–90% B; 11–16 min, 90% B. (amide column) |
| Flow Rate: | 0.3 mL/min |
| Solvent A: | 100% Double-distilled Water; 15 mM ammonium acetate; 0.3% Ammonium hydroxide |
| Solvent B: | 90% Acetonitrile/10% Double-distilled Water; 15 mM ammonium acetate; 0.3% Ammonium hydroxide |
| Chromatography Type: | HILIC |
Analysis:
| Analysis ID: | AN006912 |
| Analysis Type: | MS |
| Analysis Protocol File: | UPLC-MS-protocol.pdf |
| Chromatography ID: | CH005250 |
| Num Factors: | 29 |
| Num Metabolites: | 31 |
| Units: | ion counts |
| Analysis ID: | AN006913 |
| Analysis Type: | MS |
| Analysis Protocol File: | UPLC-MS-protocol.pdf |
| Chromatography ID: | CH005250 |
| Num Factors: | 29 |
| Num Metabolites: | 66 |
| Units: | ion counts |